HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yingying Fu Selected Research

pro-argin

5/2010Dentin hypersensitivity reduction of a new toothpaste containing 8.0% arginine and 1450 ppm fluoride: an 8-week clinical study on Chinese adults.
5/2010Instant dentin hypersensitivity relief of a new desensitizing dentifrice containing 8.0% arginine, a high cleaning calcium carbonate system and 1450 ppm fluoride: a 3-day clinical study in Chengdu, China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yingying Fu Research Topics

Disease

7Infections
05/2022 - 11/2018
3Dentin Sensitivity
01/2019 - 05/2010
2Neoplasms (Cancer)
10/2014 - 01/2014
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022
1Thromboembolism
01/2022
1Atrial Fibrillation
01/2022
1Cross Infection (Nosocomial Infection)
01/2022
1Mitral Valve Stenosis (Mitral Stenosis)
01/2022
1COVID-19
10/2020
1Papillomavirus Infections
01/2020
1Ovarian Neoplasms (Ovarian Cancer)
05/2019
1Brucellosis (Malta Fever)
11/2018
1Bacterial Infections (Bacterial Infection)
07/2018
1Cardiotoxicity
02/2015
1Heart Failure
02/2015
1Leukemia
02/2015
1AIDS-Related Complex (ARC)
02/2015
1Lung Neoplasms (Lung Cancer)
10/2014
1Poisoning
04/2014
1Hypersensitivity (Allergy)
05/2010

Drug/Important Bio-Agent (IBA)

5AerosolsIBA
01/2022 - 11/2018
3Arginine (L-Arginine)FDA Link
01/2019 - 05/2010
3Proteins (Proteins, Gene)FDA Link
11/2018 - 04/2014
2Dentifrices (Dentifrice)IBA
01/2019 - 05/2010
2Cadherins (E-Cadherin)IBA
10/2014 - 01/2014
2ToothpastesIBA
05/2010 - 05/2010
2FluoridesIBA
05/2010 - 05/2010
2Calcium Carbonate (Limestone)FDA Link
05/2010 - 05/2010
2pro-arginIBA
05/2010 - 05/2010
1Pharmaceutical PreparationsIBA
05/2022
1N-(2-cyanoethylene)urea (BA 1)IBA
01/2022
1N-methyl-valyl-amiclenomycin (BA 2)IBA
01/2022
1Vitamin KFDA Link
01/2022
1AnticoagulantsIBA
01/2022
1SesquiterpenesIBA
01/2022
1AntibodiesIBA
01/2020
1Protein Isoforms (Isoforms)IBA
01/2020
1MicroRNAs (MicroRNA)IBA
01/2020
1Fibronectins (Fibronectin)IBA
05/2019
1IntegrinsIBA
05/2019
1LigandsIBA
05/2019
1SodiumIBA
01/2019
1CalciumIBA
01/2019
1Dihydrotachysterol (AT 10)IBA
07/2018
1Doxorubicin (Adriamycin)FDA LinkGeneric
02/2015
1Anti-Bacterial Agents (Antibiotics)IBA
02/2015
1AnthracyclinesIBA
02/2015
1dihydromyricetinIBA
02/2015
1celastrolIBA
10/2014
1Histone Deacetylase InhibitorsIBA
10/2014
1CaspasesIBA
10/2014
1Histone Deacetylases (Histone Deacetylase)IBA
10/2014
1Drug CombinationsIBA
10/2014
1VorinostatFDA Link
10/2014
1RicinIBA
04/2014
1ApolipoproteinsIBA
04/2014
114-3-3 Proteins (14-3-3 Protein)IBA
04/2014
1Selenium-Binding ProteinsIBA
04/2014
1HMGB1 Protein (HMG1)IBA
04/2014
1Biological ProductsIBA
04/2014
1Lapatinib (GW572016)FDA Link
01/2014
1nutlin 3IBA
01/2014
1Gefitinib (Iressa)FDA Link
01/2014
1fluorophosphate (sodium monofluorophosphate)FDA Link
05/2010

Therapy/Procedure

1Patient Isolators (Life Island)
01/2022
1Drug Therapy (Chemotherapy)
02/2015